🚀 Investing in the Future of Health: Insights from Sergey Jakimov & LongeVC 🔬

This week on The Microdose Diet Podcast, we sat down with Sergey Jakimov, co-founder and partner at LongeVC, to discuss how longevity and biotech are reshaping our understanding of aging. Sergey’s pragmatic and disease-driven investment philosophy is redefining what it means to live longer—and better.🎯 Key Highlights:💡 Lifespan vs. Healthspan: Sergey emphasizes that living longer only matters if those extra years are vibrant and fulfilling. At LongeVC, it’s about improving healthspan, not just extending lifespan.🧠 Pragmatism in Longevity: Tackling aging through disease-specific innovations ensures measurable outcomes and clear paths for success—essential for aligning with venture capital and big pharma goals.🔬 Breakthrough Focus Areas:Therapies for age-related diseases like cancer and Alzheimer’s.Cutting-edge diagnostics addressing unmet needs.AI-driven platforms accelerating drug discovery.🤝 Collaboration is Key: Progress in longevity thrives on partnerships—between researchers, startups, VCs, and big pharma.🎙️ Dive into the full conversation to explore why Sergey believes a balanced approach between vision and practical results is crucial for advancing the field of health and wellness.🎥 Watch now and join the conversation! Let us know: What’s more important to you—living longer or living better? 👇#Longevity #Healthspan #Innovation #VentureCapital #TheMicrodoseDietPeggy Van de Plassche is a value creation strategist and senior advisor with over 20 years of experience in private equity, financial services, healthcare, and technology. She works with investment firms, boards, and C-suite leaders to accelerate portfolio company performance, drive operational transformation, and unlock long-term value. Peggy specializes in the execution of complex value creation plans—spanning capital allocation, digital enablement, transaction advisory, and leadership alignment. Her work consistently bridges strategy and implementation, helping investors and operators maximize EBITDA and enterprise value. A founding board member of Invest in Canada, she also brings deep expertise in public-private partnerships and institutional capital deployment—critical levers for competitive advantage in today’s global landscape. Her clients have included BMO, CI Financial, HOOPP, OMERS, GreenShield Canada, Nicola Wealth, and Power Financial. Learn more at peggyvandeplassche.com.#privateequity #privatemarkets #alternativeinvestments #investing #investments #invest #venturecapital #investor #entrepreneur #digitaltransformation #ai #exit #tech #technology #finance #financialservices #healthcare